Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis

NCT04384458 is registered in ClinicalTrials.gov with Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara as lead sponsor.

NCT NCT04384458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04384458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis
Lead sponsor
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
Phase
Not applicable
Overall status
Unknown status
Start date
July 20, 2020
Completion date
April 30, 2021
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infections